Lisa McClain, Representative
sell disclosed on 22 Oct 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Public company research profile
This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.
Company research history
nt HCA Healthcare, Inc. Common Stock (HCA)
Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.
19 disclosures
9 insiders
0 cluster signals
0.0% avg. 30d outcome
Company facts
- Ticker / ISIN
- HCA / Not available
- Exchange
- Not available
- Country
- US
- Sector
- Not available
Related insiders
Jared Moskowitz
Representative, 2 disclosures
Josh Gottheimer
Representative, 7 disclosures
Julie Johnson
Representative, 1 disclosure
Kathy Manning
Representative, 2 disclosures
Lisa McClain
Representative, 2 disclosures
Rob Bresnahan
Representative, 1 disclosure
Susie Lee
Representative, 1 disclosure
Valerie Hoyle
Representative, 2 disclosures
Zoe Lofgren
Representative, 1 disclosure
Disclosure history
Lisa McClain, Representative
buy disclosed on 12 Sept 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Valerie Hoyle, Representative
buy disclosed on 12 Sept 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Valerie Hoyle, Representative
sell disclosed on 12 Sept 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Jared Moskowitz, Representative
buy disclosed on 27 Jun 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Jared Moskowitz, Representative
buy disclosed on 27 Jun 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Julie Johnson, Representative
sell disclosed on 14 May 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Rob Bresnahan, Representative
sell disclosed on 27 Mar 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Josh Gottheimer, Representative
sell disclosed on 7 Apr 2024 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Josh Gottheimer, Representative
sell disclosed on 8 Dec 2023 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Josh Gottheimer, Representative
sell disclosed on 8 Dec 2023 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Josh Gottheimer, Representative
sell disclosed on 21 Aug 2023 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Zoe Lofgren, Representative
sell disclosed on 6 Jun 2023 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Josh Gottheimer, Representative
sell disclosed on 17 Feb 2023 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Susie Lee, Representative
sell disclosed on 29 Dec 2022 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Josh Gottheimer, Representative
sell disclosed on 16 Oct 2022 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Kathy Manning, Representative
sell disclosed on 14 Sept 2022 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Kathy Manning, Representative
buy disclosed on 10 Aug 2022 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Josh Gottheimer, Representative
sell disclosed on 22 Jul 2022 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%